734 Endo (Mycophenolate mofetil 250 mg)

This pill with imprint "734 Endo" is Blue & Orange, Capsule-shape and has been identified as Mycophenolate mofetil 250 mg. It is manufactured by Endo Pharmaceuticals Inc..

Mycophenolate mofetil is used in the treatment of nephrotic syndrome; pulmonary fibrosis; myasthenia gravis; systemic lupus erythematosus; autoimmune hepatitis (and more), and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Mycophenolate mofetil 250 mg is not a controlled substance under the Controlled Substance Act (CSA).

Mycophenolate mofetil

Imprint:

734 Endo

Strength:

250 mg

Color:

Blue & Orange

Shape:

Capsule-shape

Availability:

Prescription only

Drug Class:

Selective immunosuppressants

Pregnancy Category:

D - Positive evidence of risk

CSA Schedule:

Not a controlled drug

Manufacturer:

Endo Pharmaceuticals Inc.

National Drug Code (NDC):

60951-0734

Inactive Ingredients:

ammonia
croscarmellose sodium
magnesium stearate
microcrystalline cellulose
potassium hydroxide
povidone
propylene glycol
shellac

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.